Position in GMAB
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$830,199
-$347,561 QoQ
Shares Held
30,943
-19.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Derivatives in GMAB
reported options exposure · as of Mar 31, 2023CallValue
$3,776
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. GMAB ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $830,199 | 30,943 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,177,760 | 38,239 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,030,746 | 98,818 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,807,149 | 87,471 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $391,892 | 20,015 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $389,577 | 18,667 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $482,552 | 19,793 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $579,723 | 23,069 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $555,725 | 18,580 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $538,890 | 16,925 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $759,890 | 21,545 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $330,001 | 8,682 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $205,789 | 5,450 | Shares | Defined | 2023-05-11 | |
| 2023-03-31 | $3,776 | 100 | Call | Defined | 2023-05-11 | |
| 2022-12-31 | $1,067,253 | 25,183 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $151,394 | 4,712 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $155,169 | 4,776 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $194,139 | 5,366 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $211,959 | 5,358 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,764,342 | 40,374 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $739,183 | 18,104 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $347,011 | 10,570 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,821,225 | 93,980 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $3,223,948 | 88,062 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,948,937 | 87,015 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $295,682 | 13,954 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||